Browsing by Subject "PCSK9"
Now showing items 1-2 of 2
-
PCSK9i: proprotein convertase subtilisin/kexin type 9 inhibitor a new phase of lipid-lowering treatment
(BRAC University, 2023-02)One of the largest global causes of morbidity and mortality is cardiovascular disease (CVD). Elevated low-density lipoprotein (LDL) levels and adverse cardiovascular outcomes are linked to increased levels of the proprotein ... -
Review on CRISPR in cardiac repair
(BRAC University, 2023-12)This thesis investigates the transformative potential of CRISPR-Cas9 technology in the realm of cardiac repair. Since cardiovascular illnesses are the leading cause of morbidity and mortality globally, innovative strategies ...